Today's rapid development of the pharmaceutical industry，New medicine appears like mushrooms，Change the pattern of the global pharmaceutical market。But in the Chinese market，There are still some fields in a state of almost monopoly。Relying on Zhongkang CMH data，Xinkangjie summarizes some of the drug markets that have been dominated by a few companies (the data of this article is calculated at the 2015 market retail price)。

 

  Insulin preparations

 

  Clinical insulin preparations are mainly used in patients with type I diabetes and 30-40%patients with type II diabetes。According Stake Sports BettingStake Sports Bettingto Zhongkang CMH statistics，The total market of insulin preparations in 2015 reached 17.4 billion yuan。Novo and Nord、Lilly、Sanofori relied on its second、Three -generation insulin preparation products account for 60%、14%、12%market，Can be described as the three major hegemons of insulin preparations。

 

  But in this field，Domestic Enterprise Tonghua Dongbao、Gan Li Pharmaceutical、Fosun Group and other rising shows have gradually replaced imports。And the products under domestic enterprises will also enrich the current single product line，It provides follow -up forces for further competitive insulin markets。

 

  Tobacco acid -based blood lipids (Aximo)

 

  Bloodycin -lowering drugs are mostly used for combined with other blood lipid drugs，The market is less than other lipid -lowering drugs than other lipids。Zhongkang CMH data shows that in 2015 tobacco -lipid -lowering the blood lipid -lowering drug market is about 260 million，Lunan Pharmaceutical and China Resources Pharmaceuticals are 65%in market share, respectively、12%ranks first in the market、Two names。The Agemomis Capsule and Disposter of Lunan Pharmaceuticals were earlier than Pfizer，Pfizer's Agememi has failed to perform in the market。

 

  Last year，Lunan Pharmaceutical submitted a new drug registration application for Agelmus and Ruhouvas，It is still in the review stage，It is not difficult to see Stake Sports Bettingthe determination of Lunan stake betting appPharmaceutical Expand such drug product lines。

 

  & Beta; Remnant blocker drug

 

  & Beta; Remark blockers are mainly used for diseases such as hypertension and angina pectoris，Many listed products，Meitololol、Pesorol、Pluglol、Eslolol, etc.。The market size of this type of drug in 2015 was about 5.7 billion，Astrikang、Merck accounted for 56%、16%of the market share，Two companies occupy most markets。

 

  Calcium phosphatase inhibitors (immunosuppressive agent)

 

  Calcium phosphatase inhibitors clinically used for transplanting immune，The products listed on the market are mainly other。According to Zhongkang CMH monitoring，The market size is 4.8 billion yuan，Ansailai and East China Medicine are 53%、18%of the market sales accounted for the first、Two names。Among them, Anstelai mainly occupies the leading position of the market with various preparation products of his Kmomis，East China Pharmaceutical's product line is covered with cyclosporine、His Kemodo and Silomis multiple drugs。

 

  cytotoxic immunosuppressive agent

 

  cytotoxic immunosuppressive agents are mainly based on the main products of wheatcin phenol.，Used for autoimmune diseases such as mob、Blus Skybrase、Systemic lupus erythematosus、Psoriasis, etc.。Zhongkang CMH data display，Total market volume of cytotoxic immunosuppressive agents is about 2.8 billion yuan，Roche and East China Pharmaceutical almost monopolized this type of drug market。Roche stake betting apptakes up nearly 79%of Stake Sports Bettingthe market，East China Medicine occupies 14%of the market。

 

  m cholkine receptor antagonist (antisic asthma)

 

  M choline receptor antagonist is often used to treat asthma，Listing products have crickets for ammonium bromide powder inhalation agent、Inhalery compound isopyloparblytic ammonium bromide solution, etc.。Zhongkang CMH data shows that the drug market has a scale of about 1.2 billion yuan。Bollinger Yinghan's market share accounts for 82%，Zhengda Tianqing accounts for 16%，The market is almost monopolized by the two。Bollinger Yinghan has 5 products under this category，New products have been launched in 2016，Follow -up of new products helps to consolidate its dominant status。

 

  Calcium Stable Drug (Bone Disease Therapy)

 

  Calcium steady -state drug belongs to orthopedic medicine，The product is mainly salmon calcium calcium，The market size is about 1.2 billion yuan。salmon calcium calcium is a polypeptide drug，At present, it is mainly nasal spray and injection liquid dosage type。Novartis occupies the largest market with 57%market share，Beijing Yingu accounted for 15%of the following。

 

  Anti -malaria medicine

 

  The total amount of anti -Plasmid drugs is not large，Only about 700 million yuan，Shanghai Pharmaceutical Group (market share accounted for 84.2%) and Sanofi (market proportion of 15.5%) accounted for more than 99%of the market。The main listed products in the antitlip -ray medicine stake online sports bettingare sulfuric acid sulfate stake betting appchlorine tablets，Its market has been monopolized by Shanghai Pharmaceutical Group and Sanofi。